Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

LMND vs ROOT vs HIPO vs OSCR vs VERX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
LMND
Lemonade, Inc.

Insurance - Property & Casualty

Financial ServicesNYSE • US
Market Cap$4.18B
5Y Perf.-41.6%
ROOT
Root, Inc.

Insurance - Property & Casualty

Financial ServicesNASDAQ • US
Market Cap$798M
5Y Perf.-75.2%
HIPO
Hippo Holdings Inc.

Insurance - Specialty

Financial ServicesNYSE • US
Market Cap$714M
5Y Perf.-89.0%
OSCR
Oscar Health, Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$5.41B
5Y Perf.-22.4%
VERX
Vertex, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$2.34B
5Y Perf.-33.3%

LMND vs ROOT vs HIPO vs OSCR vs VERX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
LMND logoLMND
ROOT logoROOT
HIPO logoHIPO
OSCR logoOSCR
VERX logoVERX
IndustryInsurance - Property & CasualtyInsurance - Property & CasualtyInsurance - SpecialtyMedical - Healthcare PlansSoftware - Application
Market Cap$4.18B$798M$714M$5.41B$2.34B
Revenue (TTM)$821M$1.56B$480M$13.30B$768M
Net Income (TTM)$-139M$56M$113M$-39M$-6M
Gross Margin47.6%17.9%40.5%17.4%63.3%
Operating Margin-16.3%4.1%24.2%0.1%-1.1%
Forward P/E29.0x114.3x34.7x19.9x
Total Debt$182M$201M$52M$430M$360M
Cash & Equiv.$385M$690M$250M$2.77B$314M

LMND vs ROOT vs HIPO vs OSCR vs VERXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

LMND
ROOT
HIPO
OSCR
VERX
StockMar 21May 26Return
Lemonade, Inc. (LMND)10058.4-41.6%
Root, Inc. (ROOT)10024.8-75.2%
Hippo Holdings Inc. (HIPO)10011.0-89.0%
Oscar Health, Inc. (OSCR)10077.6-22.4%
Vertex, Inc. (VERX)10066.7-33.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: LMND vs ROOT vs HIPO vs OSCR vs VERX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LMND and HIPO are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Hippo Holdings Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. VERX also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
LMND
Lemonade, Inc.
The Insurance Pick

LMND has the current edge in this matchup, primarily because of its strength in long-term compounding.

  • -21.6% 10Y total return vs VERX's -38.7%
  • 40.2% revenue growth vs VERX's 12.2%
  • +78.2% vs VERX's -60.8%
Best for: long-term compounding
ROOT
Root, Inc.
The Insurance Pick

ROOT is the clearest fit if your priority is growth exposure.

  • Rev growth 29.0%, EPS growth 22.4%, 3Y rev CAGR 69.6%
Best for: growth exposure
HIPO
Hippo Holdings Inc.
The Insurance Pick

HIPO is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.

  • Lower volatility, beta 1.40, Low D/E 12.0%, current ratio 0.35x
  • 23.4% margin vs LMND's -16.9%
  • 6.0% ROA vs LMND's -7.4%, ROIC 22.8% vs -36.8%
Best for: sleep-well-at-night
OSCR
Oscar Health, Inc.
The Insurance Play

Among these 5 stocks, OSCR doesn't own a clear edge in any measured category.

Best for: healthcare exposure
VERX
Vertex, Inc.
The Income Pick

VERX ranks third and is worth considering specifically for income & stability and defensive.

  • Dividend streak 0 yrs, beta 0.83
  • Beta 0.83, current ratio 0.98x
  • Lower P/E (19.9x vs 34.7x)
  • Beta 0.83 vs LMND's 2.75
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthLMND logoLMND40.2% revenue growth vs VERX's 12.2%
ValueVERX logoVERXLower P/E (19.9x vs 34.7x)
Quality / MarginsHIPO logoHIPO23.4% margin vs LMND's -16.9%
Stability / SafetyVERX logoVERXBeta 0.83 vs LMND's 2.75
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)LMND logoLMND+78.2% vs VERX's -60.8%
Efficiency (ROA)HIPO logoHIPO6.0% ROA vs LMND's -7.4%, ROIC 22.8% vs -36.8%

LMND vs ROOT vs HIPO vs OSCR vs VERX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

LMNDLemonade, Inc.
FY 2025
Reportable Segment
100.0%$738M
ROOTRoot, Inc.

Segment breakdown not available.

HIPOHippo Holdings Inc.
FY 2024
Services Segment
100.0%$48M
OSCROscar Health, Inc.

Segment breakdown not available.

VERXVertex, Inc.
FY 2025
Software subscriptions
46.1%$640M
Cloud subscriptions
25.4%$353M
Software licenses
20.7%$287M
Services
7.8%$109M

LMND vs ROOT vs HIPO vs OSCR vs VERX — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLROOTLAGGINGVERX

Income & Cash Flow (Last 12 Months)

Evenly matched — HIPO and OSCR each lead in 2 of 6 comparable metrics.

OSCR is the larger business by revenue, generating $13.3B annually — 27.7x HIPO's $480M. HIPO is the more profitable business, keeping 23.4% of every revenue dollar as net income compared to LMND's -16.9%. On growth, LMND holds the edge at +55.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricLMND logoLMNDLemonade, Inc.ROOT logoROOTRoot, Inc.HIPO logoHIPOHippo Holdings In…OSCR logoOSCROscar Health, Inc.VERX logoVERXVertex, Inc.
RevenueTrailing 12 months$821M$1.6B$480M$13.3B$768M
EBITDAEarnings before interest/tax-$121M$73M$116M$40M$50M
Net IncomeAfter-tax profit-$139M$56M$113M-$39M-$6M
Free Cash FlowCash after capex$20M$181M$50M$2.8B$99M
Gross MarginGross profit ÷ Revenue+47.6%+17.9%+40.5%+17.4%+63.3%
Operating MarginEBIT ÷ Revenue-16.3%+4.1%+24.2%+0.1%-1.1%
Net MarginNet income ÷ Revenue-16.9%+3.6%+23.4%-0.3%-0.8%
FCF MarginFCF ÷ Revenue+2.4%+11.6%+10.4%+21.0%+12.9%
Rev. Growth (YoY)Latest quarter vs prior year+55.0%+12.6%+10.2%+52.6%+11.1%
EPS Growth (YoY)Latest quarter vs prior year+45.3%+95.3%+114.1%+125.0%-128.6%
Evenly matched — HIPO and OSCR each lead in 2 of 6 comparable metrics.

Valuation Metrics

ROOT leads this category, winning 2 of 6 comparable metrics.

At 12.4x trailing earnings, HIPO trades at a 97% valuation discount to VERX's 366.8x P/E. On an enterprise value basis, ROOT's 5.9x EV/EBITDA is more attractive than VERX's 26.8x.

MetricLMND logoLMNDLemonade, Inc.ROOT logoROOTRoot, Inc.HIPO logoHIPOHippo Holdings In…OSCR logoOSCROscar Health, Inc.VERX logoVERXVertex, Inc.
Market CapShares × price$4.2B$798M$714M$5.4B$2.3B
Enterprise ValueMkt cap + debt − cash$4.0B$309M$517M$3.1B$2.4B
Trailing P/EPrice ÷ TTM EPS-23.67x25.41x12.36x-12.35x366.75x
Forward P/EPrice ÷ next-FY EPS est.29.04x114.33x34.65x19.90x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple5.88x8.16x26.77x
Price / SalesMarket cap ÷ Revenue5.67x0.53x1.52x0.46x3.13x
Price / BookPrice ÷ Book value/share7.33x2.47x1.64x5.58x10.21x
Price / FCFMarket cap ÷ FCF4.15x78.49x5.11x33.76x
ROOT leads this category, winning 2 of 6 comparable metrics.

Profitability & Efficiency

HIPO leads this category, winning 6 of 9 comparable metrics.

HIPO delivers a 27.4% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-27 for LMND. HIPO carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to VERX's 1.39x. On the Piotroski fundamental quality scale (0–9), ROOT scores 6/9 vs OSCR's 4/9, reflecting solid financial health.

MetricLMND logoLMNDLemonade, Inc.ROOT logoROOTRoot, Inc.HIPO logoHIPOHippo Holdings In…OSCR logoOSCROscar Health, Inc.VERX logoVERXVertex, Inc.
ROE (TTM)Return on equity-26.5%+15.4%+27.4%-3.3%-2.5%
ROA (TTM)Return on assets-7.4%+3.7%+6.0%-0.6%-0.5%
ROICReturn on invested capital-36.8%+22.8%-2.2%
ROCEReturn on capital employed-22.7%+3.8%+6.9%-25.3%-1.2%
Piotroski ScoreFundamental quality 0–946546
Debt / EquityFinancial leverage0.34x0.51x0.12x0.44x1.39x
Net DebtTotal debt minus cash-$203M-$489M-$198M-$2.3B$46M
Cash & Equiv.Liquid assets$385M$690M$250M$2.8B$314M
Total DebtShort + long-term debt$182M$201M$52M$430M$360M
Interest CoverageEBIT ÷ Interest expense1.86x-0.57x
HIPO leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — LMND and ROOT and OSCR each lead in 2 of 6 comparable metrics.

A $10,000 investment in OSCR five years ago would be worth $9,271 today (with dividends reinvested), compared to $1,105 for HIPO. Over the past 12 months, LMND leads with a +78.2% total return vs VERX's -60.8%. The 3-year compound annual growth rate (CAGR) favors ROOT at 117.4% vs VERX's -10.6% — a key indicator of consistent wealth creation.

MetricLMND logoLMNDLemonade, Inc.ROOT logoROOTRoot, Inc.HIPO logoHIPOHippo Holdings In…OSCR logoOSCROscar Health, Inc.VERX logoVERXVertex, Inc.
YTD ReturnYear-to-date-28.3%-19.7%-8.5%+39.4%-22.8%
1-Year ReturnPast 12 months+78.2%-59.3%+12.2%+22.6%-60.8%
3-Year ReturnCumulative with dividends+234.7%+927.3%+48.3%+177.5%-28.6%
5-Year ReturnCumulative with dividends-31.2%-69.6%-88.9%-7.3%-15.6%
10-Year ReturnCumulative with dividends-21.6%-88.3%-90.5%-40.0%-38.7%
CAGR (3Y)Annualised 3-year return+49.6%+117.4%+14.0%+40.5%-10.6%
Evenly matched — LMND and ROOT and OSCR each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — OSCR and VERX each lead in 1 of 2 comparable metrics.

VERX is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than LMND's 2.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OSCR currently trades 87.7% from its 52-week high vs VERX's 34.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricLMND logoLMNDLemonade, Inc.ROOT logoROOTRoot, Inc.HIPO logoHIPOHippo Holdings In…OSCR logoOSCROscar Health, Inc.VERX logoVERXVertex, Inc.
Beta (5Y)Sensitivity to S&P 5002.75x2.30x1.40x1.84x0.83x
52-Week HighHighest price in past year$99.90$162.99$38.98$23.80$42.44
52-Week LowLowest price in past year$28.71$40.91$19.92$10.69$10.59
% of 52W HighCurrent price vs 52-week peak+54.5%+34.9%+70.4%+87.7%+34.6%
RSI (14)Momentum oscillator 0–10036.356.648.978.550.3
Avg Volume (50D)Average daily shares traded1.9M330K110K6.5M1.3M
Evenly matched — OSCR and VERX each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: LMND as "Buy", ROOT as "Hold", HIPO as "Buy", OSCR as "Hold", VERX as "Buy". Consensus price targets imply 41.9% upside for VERX (target: $21) vs -19.7% for OSCR (target: $17).

MetricLMND logoLMNDLemonade, Inc.ROOT logoROOTRoot, Inc.HIPO logoHIPOHippo Holdings In…OSCR logoOSCROscar Health, Inc.VERX logoVERXVertex, Inc.
Analyst RatingConsensus buy/hold/sellBuyHoldBuyHoldBuy
Price TargetConsensus 12-month target$72.67$75.00$28.38$16.75$20.82
# AnalystsCovering analysts151461117
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+2.0%0.0%+0.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ROOT leads in 1 of 6 categories (Valuation Metrics). HIPO leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallRoot, Inc. (ROOT)Leads 1 of 6 categories
Loading custom metrics...

LMND vs ROOT vs HIPO vs OSCR vs VERX: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is LMND or ROOT or HIPO or OSCR or VERX a better buy right now?

For growth investors, Lemonade, Inc.

(LMND) is the stronger pick with 40. 2% revenue growth year-over-year, versus 12. 2% for Vertex, Inc. (VERX). Hippo Holdings Inc. (HIPO) offers the better valuation at 12. 4x trailing P/E (114. 3x forward), making it the more compelling value choice. Analysts rate Lemonade, Inc. (LMND) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — LMND or ROOT or HIPO or OSCR or VERX?

On trailing P/E, Hippo Holdings Inc.

(HIPO) is the cheapest at 12. 4x versus Vertex, Inc. at 366. 8x. On forward P/E, Vertex, Inc. is actually cheaper at 19. 9x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — LMND or ROOT or HIPO or OSCR or VERX?

Over the past 5 years, Oscar Health, Inc.

(OSCR) delivered a total return of -7. 3%, compared to -88. 9% for Hippo Holdings Inc. (HIPO). Over 10 years, the gap is even starker: LMND returned -21. 6% versus HIPO's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — LMND or ROOT or HIPO or OSCR or VERX?

By beta (market sensitivity over 5 years), Vertex, Inc.

(VERX) is the lower-risk stock at 0. 83β versus Lemonade, Inc. 's 2. 75β — meaning LMND is approximately 234% more volatile than VERX relative to the S&P 500. On balance sheet safety, Hippo Holdings Inc. (HIPO) carries a lower debt/equity ratio of 12% versus 139% for Vertex, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — LMND or ROOT or HIPO or OSCR or VERX?

By revenue growth (latest reported year), Lemonade, Inc.

(LMND) is pulling ahead at 40. 2% versus 12. 2% for Vertex, Inc. (VERX). On earnings-per-share growth, the picture is similar: Hippo Holdings Inc. grew EPS 235. 4% year-over-year, compared to -1865. 9% for Oscar Health, Inc.. Over a 3-year CAGR, ROOT leads at 69. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — LMND or ROOT or HIPO or OSCR or VERX?

Hippo Holdings Inc.

(HIPO) is the more profitable company, earning 12. 3% net margin versus -22. 4% for Lemonade, Inc. — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIPO leads at 13. 5% versus -21. 8% for LMND. At the gross margin level — before operating expenses — VERX leads at 60. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is LMND or ROOT or HIPO or OSCR or VERX more undervalued right now?

On forward earnings alone, Vertex, Inc.

(VERX) trades at 19. 9x forward P/E versus 114. 3x for Hippo Holdings Inc. — 94. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VERX: 41. 9% to $20. 82.

08

Which pays a better dividend — LMND or ROOT or HIPO or OSCR or VERX?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is LMND or ROOT or HIPO or OSCR or VERX better for a retirement portfolio?

For long-horizon retirement investors, Vertex, Inc.

(VERX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 83)). Root, Inc. (ROOT) carries a higher beta of 2. 30 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VERX: -38. 7%, ROOT: -88. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between LMND and ROOT and HIPO and OSCR and VERX?

These companies operate in different sectors (LMND (Financial Services) and ROOT (Financial Services) and HIPO (Financial Services) and OSCR (Healthcare) and VERX (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: LMND is a small-cap high-growth stock; ROOT is a small-cap high-growth stock; HIPO is a small-cap high-growth stock; OSCR is a small-cap high-growth stock; VERX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

LMND

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 27%
  • Gross Margin > 28%
Run This Screen
Stocks Like

ROOT

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 6%
Run This Screen
Stocks Like

HIPO

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 14%
Run This Screen
Stocks Like

OSCR

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 26%
Run This Screen
Stocks Like

VERX

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 38%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform LMND and ROOT and HIPO and OSCR and VERX on the metrics below

Revenue Growth>
%
(LMND: 55.0% · ROOT: 12.6%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.